These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34121834)

  • 1. Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries.
    Cevigney R; Leary C; Gonik B
    Infect Dis Obstet Gynecol; 2021; 2021():5536633. PubMed ID: 34121834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study.
    Li Y; Hodgson D; Wang X; Atkins KE; Feikin DR; Nair H
    Lancet Infect Dis; 2021 Sep; 21(9):1303-1312. PubMed ID: 33965062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.
    Shi T; McAllister DA; O'Brien KL; Simoes EAF; Madhi SA; Gessner BD; Polack FP; Balsells E; Acacio S; Aguayo C; Alassani I; Ali A; Antonio M; Awasthi S; Awori JO; Azziz-Baumgartner E; Baggett HC; Baillie VL; Balmaseda A; Barahona A; Basnet S; Bassat Q; Basualdo W; Bigogo G; Bont L; Breiman RF; Brooks WA; Broor S; Bruce N; Bruden D; Buchy P; Campbell S; Carosone-Link P; Chadha M; Chipeta J; Chou M; Clara W; Cohen C; de Cuellar E; Dang DA; Dash-Yandag B; Deloria-Knoll M; Dherani M; Eap T; Ebruke BE; Echavarria M; de Freitas Lázaro Emediato CC; Fasce RA; Feikin DR; Feng L; Gentile A; Gordon A; Goswami D; Goyet S; Groome M; Halasa N; Hirve S; Homaira N; Howie SRC; Jara J; Jroundi I; Kartasasmita CB; Khuri-Bulos N; Kotloff KL; Krishnan A; Libster R; Lopez O; Lucero MG; Lucion F; Lupisan SP; Marcone DN; McCracken JP; Mejia M; Moisi JC; Montgomery JM; Moore DP; Moraleda C; Moyes J; Munywoki P; Mutyara K; Nicol MP; Nokes DJ; Nymadawa P; da Costa Oliveira MT; Oshitani H; Pandey N; Paranhos-Baccalà G; Phillips LN; Picot VS; Rahman M; Rakoto-Andrianarivelo M; Rasmussen ZA; Rath BA; Robinson A; Romero C; Russomando G; Salimi V; Sawatwong P; Scheltema N; Schweiger B; Scott JAG; Seidenberg P; Shen K; Singleton R; Sotomayor V; Strand TA; Sutanto A; Sylla M; Tapia MD; Thamthitiwat S; Thomas ED; Tokarz R; Turner C; Venter M; Waicharoen S; Wang J; Watthanaworawit W; Yoshida LM; Yu H; Zar HJ; Campbell H; Nair H;
    Lancet; 2017 Sep; 390(10098):946-958. PubMed ID: 28689664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study.
    Li Y; Johnson EK; Shi T; Campbell H; Chaves SS; Commaille-Chapus C; Dighero I; James SL; Mahé C; Ooi Y; Paget J; van Pomeren T; Viboud C; Nair H
    Lancet Respir Med; 2021 Feb; 9(2):175-185. PubMed ID: 32971018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
    Baral R; Li X; Willem L; Antillon M; Vilajeliu A; Jit M; Beutels P; Pecenka C
    Vaccine; 2020 Jul; 38(33):5139-5147. PubMed ID: 32586761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children.
    Nair H; Verma VR; Theodoratou E; Zgaga L; Huda T; Simões EA; Wright PF; Rudan I; Campbell H
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S30. PubMed ID: 21501449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.
    Nair H; Nokes DJ; Gessner BD; Dherani M; Madhi SA; Singleton RJ; O'Brien KL; Roca A; Wright PF; Bruce N; Chandran A; Theodoratou E; Sutanto A; Sedyaningsih ER; Ngama M; Munywoki PK; Kartasasmita C; Simões EA; Rudan I; Weber MW; Campbell H
    Lancet; 2010 May; 375(9725):1545-55. PubMed ID: 20399493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
    Atwell JE; Lutz CS; Sparrow EG; Feikin DR
    Vaccine; 2022 Jul; 40(32):4361-4370. PubMed ID: 35725783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of birth month in the burden of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in Croatia.
    Li Y; Batinović E; Milić P; Markić J
    PLoS One; 2022; 17(9):e0273962. PubMed ID: 36054117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.
    Treskova M; Pozo-Martin F; Scholz S; Schönfeld V; Wichmann O; Harder T
    Pharmacoeconomics; 2021 Mar; 39(3):287-315. PubMed ID: 33462760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.
    Koltai M; Moyes J; Nyawanda B; Nyiro J; Munywoki PK; Tempia S; Li X; Antillon M; Bilcke J; Flasche S; Beutels P; Nokes DJ; Cohen C; Jit M
    BMC Med; 2023 Mar; 21(1):120. PubMed ID: 37004062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries.
    Li X; Willem L; Antillon M; Bilcke J; Jit M; Beutels P
    BMC Med; 2020 Apr; 18(1):82. PubMed ID: 32248817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.
    Shi T; Balsells E; Wastnedge E; Singleton R; Rasmussen ZA; Zar HJ; Rath BA; Madhi SA; Campbell S; Vaccari LC; Bulkow LR; Thomas ED; Barnett W; Hoppe C; Campbell H; Nair H
    J Glob Health; 2015 Dec; 5(2):020416. PubMed ID: 26682048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal RSV vaccine development. Where to from here?
    Gunatilaka A; Giles ML
    Hum Vaccin Immunother; 2021 Nov; 17(11):4542-4548. PubMed ID: 34499565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting.
    Campbell PT; Geard N; Hogan AB
    BMC Med; 2020 Nov; 18(1):319. PubMed ID: 33176774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries.
    Mahmud S; Baral R; Sanderson C; Pecenka C; Jit M; Li Y; Clark A
    BMC Med; 2023 Apr; 21(1):138. PubMed ID: 37038127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
    Scheltema NM; Kavelaars XM; Thorburn K; Hennus MP; van Woensel JB; van der Ent CK; Borghans JAM; Bont LJ; Drylewicz J
    Vaccine; 2018 Jul; 36(31):4693-4700. PubMed ID: 29941327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia.
    Weber MW; Milligan P; Hilton S; Lahai G; Whittle H; Mulholland EK; Greenwood BM
    Int J Epidemiol; 1999 Feb; 28(1):157-62. PubMed ID: 10195682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.
    Poletti P; Merler S; Ajelli M; Manfredi P; Munywoki PK; Nokes D; Melegaro A
    BMC Med; 2015 Mar; 13():49. PubMed ID: 25857701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Respiratory Syncytial Virus-Related Infant Community Deaths.
    Mazur NI; Löwensteyn YN; Willemsen JE; Gill CJ; Forman L; Mwananyanda LM; Blau DM; Breiman RF; Madhi SA; Mahtab S; Gurley ES; El Arifeen S; Assefa N; Scott JAG; Onyango D; Tippet Barr BA; Kotloff KL; Sow SO; Mandomando I; Ogbuanu I; Jambai A; Bassat Q; ; Caballero MT; Polack FP; Omer S; Kazi AM; Simões EAF; Satav A; Bont LJ
    Clin Infect Dis; 2021 Sep; 73(Suppl_3):S229-S237. PubMed ID: 34472576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.